Literature DB >> 8132223

TNF-alpha and IL-6 induce differentiation in the human basophilic leukaemia cell line KU812.

G Nilsson1, M Carlsson, I Jones, S Ahlstedt, P Matsson, K Nilsson.   

Abstract

The basophilic leukaemia cell line KU812 can be induced to differentiate into basophil-like cells in vitro when exposed to supernatant from the Mo T-cell line. KU812 cells express affinity receptors for IgE, produce histamine and tryptase and have the capacity for IgE-mediated histamine release. In this study we have examined the cytokines, produced by the Mo cell line, which are responsible for the observed differentiation-inducing effect in the KU812 cell line. It was shown that interleukin-6 (IL-6) and tumour necrosis factor-alpha (TNF-alpha) induced differentiation in the KU812 cells and that these cytokines were responsible for the differentiation-inducing effect of the Mo supernatant. Other cytokines tested, IL-1 beta, IL-2, IL-4, IL-5, IL-8, granulocyte-macrophage colony-stimulating factor (GM-CSF) and nerve growth factor (NGF) were without effect on the KU812 cells. KU812 was also shown to express receptors for both TNF-alpha and IL-6 after 3 days cultivation with conditioned media from the Mo T-cell line. Untreated cells showed no detectable levels of TNF-alpha or IL-6 receptors indicating induction of these receptors during differentiation. Spontaneous differentiation was shown to occur under serum-free conditions which may be the result of endogenous IL-6 production through an autocrine loop. The activity of TNF-alpha and IL-6 could be blocked by specific monoclonal antibodies (mAb) to the respective cytokine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132223      PMCID: PMC1422293     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

1.  Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro. Relationship to cell surface receptor.

Authors:  C Peetre; U Gullberg; E Nilsson; I Olsson
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

2.  Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.

Authors:  S J Collins; R C Gallo; R E Gallagher
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

3.  Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins.

Authors:  H Saito; K Hatake; A M Dvorak; K M Leiferman; A D Donnenberg; N Arai; K Ishizaka; T Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

4.  Evaluation of human peripheral blood leukocytes for mast cell tryptase.

Authors:  M C Castells; A M Irani; L B Schwartz
Journal:  J Immunol       Date:  1987-04-01       Impact factor: 5.422

5.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

6.  Constitutive and inducible expression of PDGF in the human basophilic cell line, KU 812.

Authors:  K Forsberg; G Nilsson; Z P Ren; L Hellman; B Westermark; M Nistér
Journal:  Growth Factors       Date:  1993       Impact factor: 2.511

7.  Bipotential cell differentiation of KU-812: evidence of a hybrid cell line that differentiates into basophils and macrophage-like cells.

Authors:  T Fukuda; K Kishi; Y Ohnishi; A Shibata
Journal:  Blood       Date:  1987-09       Impact factor: 22.113

8.  A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors.

Authors:  K Kishi
Journal:  Leuk Res       Date:  1985       Impact factor: 3.156

9.  Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.

Authors:  L G Larsson; M Carlsson; M Schena; M Lantz; F Caligaris-Cappio; K Nilsson
Journal:  Leukemia       Date:  1993-02       Impact factor: 11.528

10.  Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand.

Authors:  H Mitsui; T Furitsu; A M Dvorak; A M Irani; L B Schwartz; N Inagaki; M Takei; K Ishizaka; K M Zsebo; S Gillis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

View more
  6 in total

1.  Anti-interleukin 6 receptor therapy for hyper-IgD syndrome.

Authors:  Anne Musters; Paul Peter Tak; Dominique L P Baeten; Sander W Tas
Journal:  BMJ Case Rep       Date:  2015-10-29

2.  Hyposensitization to allergic reaction in rDer f 2-sensitized mice by the intranasal administration of a mutant of rDer f 2, C8/119S.

Authors:  M Yasue; T Yokota; M Fukada; T Takai; M Suko; H Okudaira; Y Okumura
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

3.  Increase in histamine content and enhancement of high affinity IgE receptor FcepsilonRI expression in the human leukemia KU812 cells upon treatment with hydrocortisone.

Authors:  T Hara; H Tachibana; K Yamada
Journal:  Cytotechnology       Date:  2000-11       Impact factor: 2.058

4.  Construction of an in vitro allergy reaction evaluation system using human leukemia cell lines.

Authors:  Sun-Yup Shim; Akira Ichikawa; Makiko Yamashita; Yoshinori Katakura; Kiichiro Teruya; Yasutaka Mochizuki; Emi Tobinaga; Sanetaka Shirahata
Journal:  Cytotechnology       Date:  2002-11       Impact factor: 2.058

5.  Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells.

Authors:  J S Marshall; I Leal-Berumen; L Nielsen; M Glibetic; M Jordana
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

6.  Induction of basophilic and eosinophilic differentiation in the human leukemic cell line KU812.

Authors:  M Yamashita; A Ichikawa; Y Katakura; Y Mochizuki; K Teruya; E H Kim; S Shirahata
Journal:  Cytotechnology       Date:  2001-07       Impact factor: 2.058

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.